1284 related articles for article (PubMed ID: 16763543)
1. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
2. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
Knapik-Kordecka M; Adamiec R; Ciosek W
Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
[TBL] [Abstract][Full Text] [Related]
3. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
4. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.
Adamiec-Mroczek J; Oficjalska-Młyńczak J; Misiuk-Hojło M
Cytokine; 2010 Mar; 49(3):269-74. PubMed ID: 20015663
[TBL] [Abstract][Full Text] [Related]
5. [The Raynaud's phenomenon: still current clinical problem].
Rychlik-Golema W; Adamiec R; Bednarska-Chabowska D; Adamiec J
Przegl Lek; 2002; 59(1):49-54. PubMed ID: 12108048
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
[TBL] [Abstract][Full Text] [Related]
8. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the profile of selected cytokines in patients with food allergy and chronic gastritis.
Bartuzi Z; Zbikowska-Gotz M; Romański B; Sinkiewicz W
Med Sci Monit; 2000; 6(6):1128-35. PubMed ID: 11208468
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 does not change the function of monocyte-derived dendritic cells grown from patients with systemic sclerosis.
Slobodin G; Pavlotzky E; Panov J; Rosner I; Kessel A; Toubi E
Immunol Invest; 2008; 37(8):841-8. PubMed ID: 18991099
[TBL] [Abstract][Full Text] [Related]
12. Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases.
Brevetti G; De Caterina M; Martone VD; Corrado S; Silvestro A; Spadaro G; Scopacasa F
Int J Clin Lab Res; 2000; 30(2):75-81. PubMed ID: 11043500
[TBL] [Abstract][Full Text] [Related]
13. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
15. Duration of Raynaud's phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients.
Dziankowska-Bartkowiak B; Zalewska A; Sysa-Jedrzejowska A
Med Sci Monit; 2004 May; 10(5):CR202-8. PubMed ID: 15114270
[TBL] [Abstract][Full Text] [Related]
16. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
Edwards CM; Marshall JM; Pugh M
Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
[TBL] [Abstract][Full Text] [Related]
18. Raynaud's phenomenon as an early sign of connective tissue diseases.
Kallenberg CG
Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
[TBL] [Abstract][Full Text] [Related]
19. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
20. [Dynamic changes and the meanings of blood cytokines in severe acute respiratory syndrome].
Wang C; Pang BS;
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Oct; 26(10):586-9. PubMed ID: 14633438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
